Valeant Pharmaceuticals Intl
(VRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRX | MDGL | GRFS | ||
| Company | Valeant Pharmaceuticals Intl | Madrigal Pharmaceuticals Inc | Grifols S.A. ADR | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 24.15 | 474.31 | 9.28 | ||
| High | 24.43 | 482.99 | 9.38 | ||
| Low | 23.36 | 458.07 | 9.27 | ||
| Latest | 23.40 | 464.71 | 9.32 | ||
| Change | -0.83 | -9.08 | +0.04 | ||
| % Change | -3.43% | -1.92% | +0.43% | ||
| Volume | 6,569,300 | 245,800 | 323,700 | ||
| 20-Day Average Volume | 6,685,200 | 323,605 | 438,455 | ||
| Previous Close | 24.23 | 473.79 | 9.28 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.73 | 487.03 | 9.23 | ||
| 20-Day Raw Stochastic | 18.46% | 12.44% | 68.66% | ||
| 20-Day Relative Strength | 52.09 | 37.74 | 52.23 | ||
| Weighted Alpha | +35.20 | +36.52 | +21.96 | ||
| Today's Opinion | N/A | 8% Buy | 24% Buy | ||
| Previous Opinion | N/A | 8% Buy | 16% Buy | ||
| Last Month's Opinion | N/A | 56% Buy | Hold | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.92% since 07/06/18 | -2.70% since 02/06/26 | +0.43% since 02/06/26 | ||
| Low | 23.02 on 07/09/18 | 458.07 on 02/13/26 | 9.07 on 02/11/26 | ||
| High | 24.43 on 07/13/18 | 499.55 on 02/10/26 | 9.64 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | -12.88% since 06/13/18 | -5.91% since 01/13/26 | +5.43% since 01/13/26 | ||
| Low | 22.56 on 06/28/18 | 458.00 on 02/05/26 | 8.63 on 01/20/26 | ||
| High | 27.25 on 06/14/18 | 511.94 on 01/16/26 | 9.64 on 02/10/26 | ||
| 3-Month | |||||
| %Chg | +36.44% since 04/13/18 | -9.75% since 11/13/25 | +7.13% since 11/13/25 | ||
| Low | 16.76 on 04/16/18 | 458.00 on 02/05/26 | 7.64 on 12/02/25 | ||
| High | 27.79 on 06/13/18 | 615.00 on 12/24/25 | 9.64 on 02/10/26 | ||
| 6-Month | |||||
| %Chg | -1.85% since 01/12/18 | +24.43% since 08/13/25 | -12.41% since 08/13/25 | ||
| Low | 14.44 on 03/02/18 | 351.32 on 08/18/25 | 7.64 on 12/02/25 | ||
| High | 27.79 on 06/13/18 | 615.00 on 12/24/25 | 10.84 on 08/14/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,159,814 | 10,554,029 | 6,408,059 | ||
| Shares Outstanding, K | 348,710 | 22,711 | 687,560 | ||
| Annual Sales | 8,724,000,000 | 180,130,000 | 7,804,520,000 | ||
| Annual Net Income | 2,404,000,000 | -465,890,000 | 169,800,000 | ||
| Last Quarter Sales | 1,995,000,000 | 287,270,000 | 2,180,470,000 | ||
| Last Quarter Net Income | -2,693,000,000 | -114,190,000 | 148,410,000 | ||
| 60-Month Beta | -0.38 | -1.01 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.89 on 05/08/18 | -5.08 on 11/04/25 | 0.19 on 07/28/25 | ||
| Latest Earnings Date | 08/14/18 | 02/19/26 | 02/25/26 | ||
| Most Recent Dividend | 1.000 on 11/10/10 | N/A | 0.142 on 08/12/25 | ||
| Next Ex-Dividends Date | N/A | N/A | 08/12/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 6.12 | 0.00 | 0.00 | ||